IPSEY (IPSEY) Stock Price & Analysis
IPSEY (IPSEY) rose 0.00% to USD 47.11 as of July 25, 2026 at 02:24 UTC, according to Nexqual real-time market data.
IPSEY last closed at USD 47.11; the session ranged USD 46.7–46.7 on volume of 44 shares. Market capitalization is $15.58B, with a 52-week range of USD 30.05–51.1 (PNK). Source: Nexqual, July 25, 2026 at 02:24 UTC.
Key Statistics (as of July 25, 2026 at 02:24 UTC)
| Price | USD 47.11 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 47.11 |
| Open | USD 46.7 |
| Day Range | USD 46.7 – 46.7 |
| 52-Week Range | USD 30.05 – 51.1 |
| Volume | 44 shares |
| Market Cap | $15.58B |
| Exchange | PNK |
Technical Analysis (IPSEY)
Nexqual's technical model rates IPSEY "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:24 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.5 (neutral) |
| vs SMA50 | Above (USD 46.35) |
| MACD | -0.33 (negative) |
Analyst Ratings (IPSEY)
Wall Street analysts rate IPSEY "None", per Nexqual as of July 25, 2026 at 02:24 UTC.
| Consensus Rating | None |
|---|
Earnings (IPSEY)
| Revenue Estimate | $1.06B |
|---|
Source: Nexqual, July 25, 2026 at 02:24 UTC.
Financials & Fundamentals (IPSEY)
| Total Revenue | $3.93B |
|---|---|
| Revenue Growth (YoY) | +9.30% |
| Gross Margin | +80.89% |
| Operating Margin | +26.10% |
| Profit Margin | +11.29% |
| ROE | +10.44% |
| Debt / Equity | 22.38 |
| Current Ratio | 1.96 |
| Total Cash | $1.53B |
| Total Debt | $970.40M |
| Free Cash Flow | $651.95M |
Source: Nexqual, July 25, 2026 at 02:24 UTC.
Financial Health Score (IPSEY)
Nexqual rates IPSEY's overall financial health "Strong" across five dimensions, as of July 25, 2026 at 02:24 UTC.
| Growth | Strong — Revenue +16% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 81%, operating 26% |
| Balance Sheet | Strong — $1.53B cash vs $970M debt, net cash position |
| Cash Flow | Strong — FCF $652M, 17% margin |
| Efficiency | Mixed — ROE 10%, ROA 9.6% |
Ownership (IPSEY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 330.66M |
| Float | 120.17M |
Source: Nexqual, July 25, 2026 at 02:24 UTC.
Leadership (IPSEY)
IPSEY is led by David Loew (age 58), MD, CEO & Director, per Nexqual as of July 25, 2026 at 02:24 UTC.
| MD, CEO & Director | David Loew (age 58) |
|---|---|
| Executive VP & CFO | Aymeric Le Chatelier (age 56) |
| Global Vice President of Investor Relations | Henry Wheeler M.Sc. (age 41) |
| Executive VP, Chief Product Officer & Head of GPPS | Mari Scheiffele |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SGIOY | Shionogi & Co. Ltd. | USD 8.7 | ▼ 0.57% |
| MKKGY | Merck KGaA | USD 31.88 | ▲ 2.02% |
| UCBJY | UCB S.A. | USD 139.01 | ▼ 0.04% |
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 4.82 | ▼ 0.62% |
| OTSKY | Otsuka Holdings Co. Ltd. | USD 34.02 | ▲ 1.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:24 UTC. This page is informational and not investment advice.